145 related articles for article (PubMed ID: 18829357)
1. Data mining PubChem using a support vector machine with the Signature molecular descriptor: classification of factor XIa inhibitors.
Weis DC; Visco DP; Faulon JL
J Mol Graph Model; 2008 Nov; 27(4):466-75. PubMed ID: 18829357
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
Shen MY; Su BH; Esposito EX; Hopfinger AJ; Tseng YJ
Chem Res Toxicol; 2011 Jun; 24(6):934-49. PubMed ID: 21504223
[TBL] [Abstract][Full Text] [Related]
3. SVM-based feature selection for characterization of focused compound collections.
Byvatov E; Schneider G
J Chem Inf Comput Sci; 2004; 44(3):993-9. PubMed ID: 15154767
[TBL] [Abstract][Full Text] [Related]
4. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
Li Q; Jørgensen FS; Oprea T; Brunak S; Taboureau O
Mol Pharm; 2008; 5(1):117-27. PubMed ID: 18197627
[TBL] [Abstract][Full Text] [Related]
5. GPU accelerated support vector machines for mining high-throughput screening data.
Liao Q; Wang J; Webster Y; Watson IA
J Chem Inf Model; 2009 Dec; 49(12):2718-25. PubMed ID: 19961205
[TBL] [Abstract][Full Text] [Related]
6. Identification of small molecule aggregators from large compound libraries by support vector machines.
Rao H; Li Z; Li X; Ma X; Ung C; Li H; Liu X; Chen Y
J Comput Chem; 2010 Mar; 31(4):752-63. PubMed ID: 19569201
[TBL] [Abstract][Full Text] [Related]
7. Prediction of factor Xa inhibitors by machine learning methods.
Lin HH; Han LY; Yap CW; Xue Y; Liu XH; Zhu F; Chen YZ
J Mol Graph Model; 2007 Sep; 26(2):505-18. PubMed ID: 17418603
[TBL] [Abstract][Full Text] [Related]
8. Data mining a small molecule drug screening representative subset from NIH PubChem.
Xie XQ; Chen JZ
J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
[TBL] [Abstract][Full Text] [Related]
9. Classification of cytochrome P450 1A2 inhibitors and noninhibitors by machine learning techniques.
Vasanthanathan P; Taboureau O; Oostenbrink C; Vermeulen NP; Olsen L; Jørgensen FS
Drug Metab Dispos; 2009 Mar; 37(3):658-64. PubMed ID: 19056915
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
11. QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.
Dong X; Jiang C; Hu H; Yan J; Chen J; Hu Y
Eur J Med Chem; 2009 Oct; 44(10):4090-7. PubMed ID: 19497644
[TBL] [Abstract][Full Text] [Related]
12. Prediction models of human plasma protein binding rate and oral bioavailability derived by using GA-CG-SVM method.
Ma CY; Yang SY; Zhang H; Xiang ML; Huang Q; Wei YQ
J Pharm Biomed Anal; 2008 Aug; 47(4-5):677-82. PubMed ID: 18455346
[TBL] [Abstract][Full Text] [Related]
13. Virtual screening of Abl inhibitors from large compound libraries by support vector machines.
Liu XH; Ma XH; Tan CY; Jiang YY; Go ML; Low BC; Chen YZ
J Chem Inf Model; 2009 Sep; 49(9):2101-10. PubMed ID: 19689138
[TBL] [Abstract][Full Text] [Related]
14. Improving virtual screening predictive accuracy of Human kallikrein 5 inhibitors using machine learning models.
Fang X; Bagui S; Bagui S
Comput Biol Chem; 2017 Aug; 69():110-119. PubMed ID: 28601761
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of virtual screening performance of support vector machines trained by sparsely distributed active compounds.
Ma XH; Wang R; Yang SY; Li ZR; Xue Y; Wei YC; Low BC; Chen YZ
J Chem Inf Model; 2008 Jun; 48(6):1227-37. PubMed ID: 18533644
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of high-throughput screening data with increasing levels of noise using support vector machines, recursive partitioning, and laplacian-modified naive bayesian classifiers.
Glick M; Jenkins JL; Nettles JH; Hitchings H; Davies JW
J Chem Inf Model; 2006; 46(1):193-200. PubMed ID: 16426055
[TBL] [Abstract][Full Text] [Related]
17. A comparison of different QSAR approaches to modeling CYP450 1A2 inhibition.
Novotarskyi S; Sushko I; Körner R; Pandey AK; Tetko IV
J Chem Inf Model; 2011 Jun; 51(6):1271-80. PubMed ID: 21598906
[TBL] [Abstract][Full Text] [Related]
18. Support vector machines in HTS data mining: Type I MetAPs inhibition study.
Fang J; Dong Y; Lushington GH; Ye QZ; Georg GI
J Biomol Screen; 2006 Mar; 11(2):138-44. PubMed ID: 16418315
[TBL] [Abstract][Full Text] [Related]
19. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
Hou T; Wang J; Li Y
J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
[TBL] [Abstract][Full Text] [Related]
20. Large-scale annotation of small-molecule libraries using public databases.
Zhou Y; Zhou B; Chen K; Yan SF; King FJ; Jiang S; Winzeler EA
J Chem Inf Model; 2007; 47(4):1386-94. PubMed ID: 17608408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
